BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10580746)

  • 1. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
    Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
    Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
    Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
    Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice.
    Newey PJ; Thakker RV
    Endocr Pract; 2011; 17 Suppl 3():8-17. PubMed ID: 21454234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality.
    Shan L; Nakamura Y; Murakami M; Nakamura M; Naito A; Kawahara K; Utsunomiya H; Mori I; Kakudo K
    Jpn J Cancer Res; 1999 Sep; 90(9):965-9. PubMed ID: 10551325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline and somatic genetic changes in multicentric tumors obtained from a patient with multiple endocrine neoplasia type 1.
    Naruoka A; Ohnami S; Nagashima T; Serizawa M; Ohshima K; Ohnami S; Urakami K; Horiuchi Y; Kiyozumi Y; Abe M; Nakajima T; Sugiura T; Uesaka K; Kusuhara M; Yamaguchi K
    Hum Genome Var; 2017; 4():17013. PubMed ID: 28503312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
    Storan D; Almeamar H; Flynn S; Sherlock M; Colombie M; Skehan SJ; Crowley RK
    Eur J Endocrinol; 2024 May; ():. PubMed ID: 38781437
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to: The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
    Kostiainen I; Schildt J; Parviainen H; Ryhänen EM; Schalin-Jäntti C
    Eur J Endocrinol; 2024 Jun; ():. PubMed ID: 38828659
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism and recent updates on insulin-related disorders.
    Kumar S; Senapati S; Bhattacharya N; Bhattacharya A; Maurya SK; Husain H; Bhatti JS; Pandey AK
    World J Clin Cases; 2023 Sep; 11(25):5840-5856. PubMed ID: 37727490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two nonsense somatic mutations in
    Qi C; Duan J; Shi Q; Wang M; Yan C
    FEBS Open Bio; 2018 Feb; 8(2):295-301. PubMed ID: 29435419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma: pathophysiology, localization and management.
    Shin JJ; Gorden P; Libutti SK
    Future Oncol; 2010 Feb; 6(2):229-37. PubMed ID: 20146582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
    Shen HC; He M; Powell A; Adem A; Lorang D; Heller C; Grover AC; Ylaya K; Hewitt SM; Marx SJ; Spiegel AM; Libutti SK
    Cancer Res; 2009 Mar; 69(5):1858-66. PubMed ID: 19208834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
    Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
    Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
    Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
    Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1.
    Agarwal SK
    Front Horm Res; 2013; 41():1-15. PubMed ID: 23652667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma.
    Ludwig L; Schleithoff L; Kessler H; Wagner PK; Boehm BO; Karges W
    Endocr J; 1999 Aug; 46(4):539-44. PubMed ID: 10580746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.